Ho-Young Huh

Ho-Young Huh

Fortune : 615 524 $ au 31/05/2025

56 ans
Health Technology
Consumer Services
Health Services

Profil

Ho-Young Huh was the founder of Rezolute, Inc. founded in 2010, serving as Vice Chairman from 2018 to 2019.
Dr. Huh is the founder of Konus Advisory Group, Inc. founded in 2012, serving as Managing Director from 2012 to 2014.
Dr. Huh is the founder of StemPar Sciences, Inc. founded in 2012, serving as Chairman since 2012.
Dr. Huh is the founder of pH Pharma Co., Ltd. founded in 2015, serving as Chief Executive Officer since 2015.
Dr. Huh was the founder of Peak Bio, Inc. founded in 2016, serving as Executive Chairman in 2024.
Dr. Huh is also the founder of Healthcare & Humanity Foundation.
Current positions include Chief Executive Officer at Peak Bio Co. Ltd., Chairman at Pliant Therapeutics, Inc. since 2017, Chairman at Akari Therapeutics Plc since 2024, and Director roles at SciDose LLC, Interplast, SFJAZZ, and Resurge International.
Former positions include Chairman, President & Chief Executive Officer at BiPar Sciences, Inc. from 2008 to 2010; Chairman at Geron Corp.
from 2011 to 2018; Chairman at CytomX Therapeutics Holdings LLC; Chairman at Epizyme, Inc. from 2009 to 2012; Chairman at CytomX Therapeutics, Inc. from 2012 to 2018; Director at Nektar Therapeutics in 2009; Director at Calibra Medical LLC; Director at Abbott Biotherapeutics Corp.
in 2010; Non-Executive Director at Addex Therapeutics Ltd. from 2012 to 2014; Director at The Bay Area Bioscience Association; Independent Director at EOS SpA; Director at Synchronicity Pharma, Inc.; Director at Bionik Laboratories Corp.; Director at 4D Molecular Therapeutics, Inc.; Director at Ascendancy Healthcare, Inc.; Director at Eidos Therapeutics, Inc.; Partner at McKinsey & Co., Inc.; and Managing Partner at Quintessa Investment Co. Ltd. Education includes undergraduate studies at Dartmouth College and doctorate degrees from Weill Cornell Medical College and Cornell University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,1 %
15/06/2026 45 924 ( 0,1 % ) 393 721 $ 31/05/2026
11/06/2026 99 759 ( 0,16 % ) 125 696 $ 31/05/2026
01/06/2026 9 610 622 000 ( 18,07 % ) 96 106 $ 31/05/2025

Postes actifs de Ho-Young Huh

SociétésPosteDébut
PLIANT THERAPEUTICS, INC. Président 01/05/2018
AKARI THERAPEUTICS, PLC Président -
Directeur/Membre du Conseil -
Directeur Général 22/09/2015
Directeur Général -
Directeur/Membre du Conseil -
Fondateur 01/01/2012
Directeur/Membre du Conseil 19/04/2011
Directeur/Membre du Conseil 19/04/2011

Anciens postes connus de Ho-Young Huh

SociétésPosteFin
░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ho-Young Huh

Formation de Ho-Young Huh

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Healthcare & Humanity Foundation

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Ho-Young Huh
🔇